scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1004219008 |
P356 | DOI | 10.1186/S12885-015-1584-3 |
P932 | PMC publication ID | 4535277 |
P698 | PubMed publication ID | 26272451 |
P5875 | ResearchGate publication ID | 281056492 |
P50 | author | Michael P. Lux | Q37372079 |
Alexander Hein | Q52723502 | ||
Peter A. Fasching | Q64005064 | ||
Matthias W. Beckmann | Q72940290 | ||
P2093 | author name string | Claudia Rauh | |
Michael G Schrauder | |||
Sebastian M Jud | |||
Falk C Thiel | |||
Thomas Hildebrandt | |||
Sandra-Maria Knetzger | |||
P2860 | cites work | Audio-visual presentation of information for informed consent for participation in clinical trials | Q24242462 |
Patient recruitment: the costly and growing bottleneck in drug development | Q34508466 | ||
Participants' understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis | Q35211304 | ||
Volunteers or victims: patients' views of randomised cancer clinical trials | Q36081054 | ||
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy | Q36616439 | ||
A comparison of patient knowledge of clinical trials and trialist priorities | Q36897782 | ||
Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis | Q37660589 | ||
Organizational barriers to physician participation in cancer clinical trials. | Q38456986 | ||
Patient perception of a long-term clinical trial: experience using a close-out questionnaire in the Studies of Left Ventricular Dysfunction (SOLVD) Trial. SOLVD Close-out Working Group | Q38570888 | ||
Attitudes toward clinical trials among patients and the public | Q38578716 | ||
Hope for a cure and altruism are the main motives behind participation in phase 3 clinical cancer trials. | Q39263130 | ||
??? | Q56786696 | ||
Knowledge and understanding among cancer patients consenting to participate in clinical trials | Q40042701 | ||
Focus group interviews examining attitudes to randomised trials among breast cancer patients and the general community | Q40842478 | ||
Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic | Q41442232 | ||
Levels of knowledge and perceived understanding among participants in cancer clinical trials - factors related to the informed consent procedure. | Q44608892 | ||
Determinants of patient participation in clinical studies requiring informed consent: why patients enter a clinical trial | Q47606092 | ||
Clinical trials and healthy volunteers | Q48367211 | ||
Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret. | Q50954453 | ||
The impact of disease severity on the informed consent process in clinical research. | Q52049125 | ||
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. | Q53300225 | ||
Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. | Q54117864 | ||
Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training | Q56786171 | ||
Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision | Q58854485 | ||
Strategic physician communication and oncology clinical trials | Q73042298 | ||
Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet | Q74660681 | ||
Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists | Q78112943 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 587 | |
P577 | publication date | 2015-08-14 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases | |
P478 | volume | 15 |
Q58699631 | Cancer Health Literacy and Willingness to Participate in Cancer Research and Donate Bio-Specimens |
Q45887603 | Combined cell-gene therapy for lung cancer: rationale, challenges and prospects. |
Q38783324 | Immuno-oncology for renal cell carcinoma treatment: future perspectives for combinations and sequences with molecularly targeted agents |
Q38939419 | Innovation in non-Hodgkin lymphoma drug discovery: what needs to be done? |
Q38772165 | The development of high-content screening (HCS) technology and its importance to drug discovery |
Q88432061 | The effects of an educational program for non-physician health care providers regarding fertility preservation |
Search more.